Specialist and Interdisciplinary Chemistry / Medicines and chemical biology
Natural product biosynthesis
Acetate, mevalonate and shikimate pathways; polyketide synthases, terpenes, alkaloids and engineered biosynthesis.
UndergradPhDIn a nutshell
Living things make an enormous range of complex molecules that are not needed for basic survival but help them defend themselves, signal or compete: antibiotics, toxins, scents and pigments. Natural product biosynthesis is the study of how they do it. The surprise is how few starting materials are involved. Almost everything comes from a handful of building blocks, mainly acetyl units, five-carbon isoprene units and amino acids, stitched together by enzymes using reactions an organic chemist would recognise, such as Claisen condensations and carbocation cyclisations. Knowing the route lets scientists predict structures, find new compounds hidden in genomes and reprogram microbes to make drugs. The antimalarial artemisinin, for example, is now partly made from a precursor brewed by engineered yeast.
Three main pathways
Acetate (polyketide) pathway. Acetyl-CoA is carboxylated to malonyl-CoA. A starter acyl group then undergoes repeated decarboxylative Claisen condensations with malonyl units: loss of CO_2 generates the enolate nucleophile, which attacks a thioester, extending the chain by two carbons as a β-ketothioester. Fatty acid synthase reduces every β-keto group fully (ketoreduction, dehydration, enoyl reduction). Polyketide synthases may skip some or all of these steps, so the oxygen pattern of the product records which reductions happened. A fully unreduced chain cyclises by aldol or Claisen reactions to aromatic rings, which is why so many fungal and plant phenols have oxygen on alternate carbons, as in orsellinic acid.
Mevalonate pathway (terpenes and steroids). Three acetyl-CoA give HMG-CoA, which HMG-CoA reductase (the target of statins) reduces with NADPH to mevalonate. Phosphorylation and decarboxylative elimination give isopentenyl diphosphate (IPP), which isomerises to dimethylallyl diphosphate (DMAPP). Loss of diphosphate from DMAPP gives an allylic cation that is attacked by the alkene of IPP; deprotonation completes a head-to-tail C_5 addition. Repeating this gives geranyl (C_{10}), farnesyl (C_{15}) and geranylgeranyl (C_{20}) diphosphates. Terpene cyclases then ionise these and steer cation cascades (cyclisations, hydride and methyl shifts) to specific skeletons. Two farnesyl units join through their C1 carbons to give squalene (C_{30}), which is epoxidised and cyclised to lanosterol and on to cholesterol. Bacteria and plant plastids make IPP by the separate methylerythritol phosphate (MEP) pathway.
Shikimate pathway. Phosphoenolpyruvate and erythrose 4-phosphate are combined and cyclised to shikimic acid, then chorismic acid, the branch point to phenylalanine, tyrosine and tryptophan. Phenylalanine ammonia lyase gives cinnamic acid, the entry to lignin, flavonoids (with three malonyl units) and coumarins. Glyphosate kills plants by blocking the shikimate enzyme EPSP synthase.
Alkaloids
Alkaloids come from amino acids. A recurring step is a Mannich-type reaction between an amine and an iminium ion. In the Pictet–Spengler reaction catalysed by strictosidine synthase, tryptamine condenses with the aldehyde of secologanin (a terpenoid) and the indole attacks the iminium ion, giving strictosidine, the precursor of more than 2000 monoterpene indole alkaloids including quinine and vinblastine.
Labelling experiments
Pathways were worked out by feeding ^{13}C- or ^{14}C-labelled precursors. Feeding [1,2-^{13}C_2]acetate and finding intact ^{13}C–^{13}C couplings in the NMR spectrum of the product reveals which pairs of carbons came from the same acetate unit.
Modern biosynthesis research is driven by genomics. Genes for a natural product usually cluster together in bacteria and fungi, and tools such as antiSMASH predict biosynthetic gene clusters and even rough structures from sequence. Most sequenced Streptomyces genomes carry 20 to 40 clusters, far more than the compounds seen under lab conditions, so much effort goes into waking up these silent clusters by heterologous expression, promoter replacement or co-culture.
Modular type I PKSs and nonribosomal peptide synthetases (NRPSs) are the classic engineering targets because each module adds and tailors one unit. The erythromycin synthase (DEBS) is the model: three large proteins, six extension modules plus a loading module, a thioesterase that macrocyclises the product. Swapping acyltransferase domains to load different extender units, or deleting reductive domains, has produced new macrolides, but yields often collapse because domains interact through poorly understood interfaces. Cryo-EM structures of whole modules since the mid 2010s have changed how module boundaries are chosen for swaps.
Synthetic biology now reassembles entire plant pathways in microbes. Engineered yeast producing artemisinic acid, and later strains making opioids and the anticancer precursors of vinblastine, show that dozens of genes from several organisms can be combined, although titres are often too low for manufacture. Plant pathway discovery leans on transcriptomics, co-expression analysis and transient expression in Nicotiana benthamiana.
Enzymology has its own open questions: how terpene cyclases control carbocation cascades without making by-products, how radical SAM enzymes perform unusual C–C couplings, and how pericyclases catalyse Diels–Alder reactions in nature. Biocatalytic use of these enzymes in total synthesis, sometimes after directed evolution, is a fast-growing area.
Key points
- Most natural products come from acetyl-CoA, isoprene (C_5) units, shikimate or amino acids.
- Polyketide chains grow by decarboxylative Claisen condensations; the extent of reduction after each step sets the oxygen pattern.
- IPP and DMAPP join head-to-tail through an allylic cation to build GPP, FPP and GGPP, which terpene cyclases fold into ring systems.
- The shikimate pathway gives aromatic amino acids, phenylpropanoids and flavonoids.
- Gene clusters, heterologous expression and module swapping let researchers discover and engineer new compounds.
Check yourself
5 questions
1Which enzyme of the mevalonate pathway is inhibited by statins?
Statins block the NADPH reduction of HMG-CoA to mevalonate, the committed step that limits cholesterol synthesis.
2What drives each chain-extension step in polyketide and fatty acid biosynthesis?
Decarboxylation makes the Claisen condensation effectively irreversible and adds a two-carbon unit to the chain.
3Farnesyl diphosphate contains how many carbon atoms?
DMAPP (C_5) plus two IPP units (C_5 each) gives the C_{15} farnesyl unit; geranyl is C_{10}.
4A product made from fed [1,2-^{13}C_2]acetate shows ^{13}C–^{13}C coupling between C3 and C4 but not between C4 and C5. What does this show?
Intact coupling appears only between carbons that stayed bonded from the same doubly labelled acetate molecule.
5In a modular type I PKS, deleting the ketoreductase domain of one module would most likely give a product with what change?
Each module tailors its own β-keto group; without its KR the β-keto group passes on unreduced, leaving a carbonyl at that position.
Read more
Recent preprints on this topic
- Loading…
Matched by keyword from ChemRxiv via Crossref. Not peer-reviewed; read critically.